Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal
Kimberly-Clark NASDAQ:KMB has offered concessions to address EU antitrust concerns about its $40 billion bid for Tylenol maker Kenvue NYSE:KVUE, a filing on the European Commission website showed on Wednesday.The European Commission, which acts as the EU competition enforcer, did not provide detail…